Needle-Free Drug Delivery Devices Market Size to Exceed $28.86 Billion by 2029 | Growth and Industry Drivers
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Fast Is The Needle-Free Drug Delivery Devices Market Expected to Grow Between 2025 And 2029?
In recent years, there has been a swift expansion in the market size of needle-free drug delivery devices. The market, standing at $16.7 billion in 2024, is projected to rise to $18.67 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 11.8%. This growth during the historic period can be associated with several factors including the rising prevalence of chronic illnesses, increased interest in painless drug administration methods, a growing elderly population, a focus on patient safety and adherence, regulatory support favoring needle-free technologies, and growth in the pharmaceutical industry.
What Growth Rate Is Anticipated for the Needle-Free Drug Delivery Devices Market in the Coming Years?
In the coming years, robust growth is expected in the market for needle-free drug delivery devices, with a projected size of $28.86 billion by 2029, expanding at a compound annual growth rate (CAGR) of 11.5%. This substantial growth during the forecast period can be accredited to the escalating demand for pain-free drug administration, increased emphasis on patient-oriented healthcare services, wider applications in child and elderly care, increased occurrence of chronic diseases requiring regular injections, advancements in technology improving device productivity and user-friendliness, broadening healthcare access in developing markets, and higher investment in R&D for advanced delivery systems. The predicted trends during this period include a surge in the use of wearable and connected devices, the rise of innovative microfluidic technologies, a shift towards child-friendly needle-free solutions, the application of AI and machine learning algorithms, and a growing trend of use in home healthcare environments.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15615&type=smp
Who Are the Leading Companies in the Needle-Free Drug Delivery Devices Market?
Major companies operating in the needle-free drug delivery devices market are Pfizer Inc., Merck & Co. Inc., Bayer AG, 3M Company, Medtronic plc, Novo Nordisk AS, Becton, Dickinson and Company, Endo International plc, Insulet Corporation, Purdue Pharma L.P., Antares Pharma Inc., MannKind Corporation, Med-Jet Inc., Portal Instruments, PharmaJet, Inovio Pharmaceuticals, Inc., National Medical Products Inc., Mika Medical Co. Ltd., Medical International Technology Inc. (MTI), NanoPass Technologies Ltd., PenJet Corporation, Akra Dermojet S.A., NuGen Medical Devices Inc., Crossject SA, Injex Pharma AG
What Are the Key Drivers of the Needle-Free Drug Delivery Devices Market?
The needle-free drug delivery device market is projected to grow due to the escalating incidence of diabetes. Diabetes, characterized by elevated blood sugar levels due to insufficient insulin production or the body’s poor use of insulin, is a chronic health concern. Factors like inactivity, unhealthy eating habits, genetic factors, urbanization, and aging populations, along with limited healthcare access and increasing global obesity rates, contribute to the increase in diabetes. Non-needle drug delivery methods offer a different approach to traditional injections for diabetes management. These alternatives, including jet injectors or transdermal patches, administer insulin through the skin without the need for needles, reducing injection-linked discomfort and anxiety and increasing comfort. The National Health Service, a government department based in the UK, reported in June 2024 that in 2023, the NHS discovered an extra 549,000 individuals in England at risk of developing type 2 diabetes. This discovery increased the total number of people with non-diabetic hyperglycemia or pre-diabetes registered with a GP to 3,615,330, a notable rise from 3,065,825 in 2022, showing an increase of almost 20%. As such, the rising occurrence of diabetes is fuelling the expansion of the needle-free drug delivery device market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=15615&type=smp
What Are the Key Market Segments in the Needle-Free Drug Delivery Devices Industry?
The needle-free drug delivery devices market covered in this report is segmented –
1) By Device Type: Inhalers, Jet Injectors, Novel Needles, Transdermal Patches, Other Device Types
2) By Application: Pain Management, Vaccine Delivery, Pediatric Injections, Insulin Delivery, Other Applications
3) By End-User: Hospitals And Clinics, Home Healthcare
Subsegments:
1) By Inhalers: Dry Powder Inhalers (Dpi), Metered Dose Inhalers (Mdi), Nebulizers
2) By Jet Injectors: High-Pressure Jet Injectors, Spring-Powered Jet Injectors, Battery-Operated Jet Injectors
3) By Novel Needles: Micro-Needle Arrays, Nano-Needle Arrays
4) By Transdermal Patches: Microneedle Patches, Conventional Patches ( Nicotine, Hormonal, Pain Relief)
5) By Other Device Types: Oral Drug Delivery Devices, Implantable Drug Delivery Systems, Sublingual Drug Delivery Devices
What Are the Latest Trends in the Needle-Free Drug Delivery Devices Market?
Prominent players in the needle-free drug delivery device industry are prioritizing innovative solutions, such as dual chamber inhalers, to improve their effectiveness, simplify their use, and meet the changing requirements of patients and health care professionals. This device, equipped with two separate compartments for different medicines, facilitates the combination of multiple drugs in one inhaler, hence simplifying treatment and increasing patient convenience. For example, Berry Global, a plastic manufacturing company from the US, launched BerryHaler, an innovative dry powder inhaler (DPI), in April 2024 with the aim to transform patient-focused healthcare solutions. Not only does this dual-chamber inhaler feature a dose counter for accurate medication administration, but its all-plastic composition without any metal parts also makes it an optimal solution for multifaceted inhalation treatments. This design simplifies dosage regulation and effective combination of multiple drugs. The inclusion of a bi-directional mouthpiece cover for comfort and cleanliness, alongside audio cues to ensure correct use, are among the advanced features of this device. Furthermore, the embedded dose counter aids in tracking medication use precisely, reducing chances of dosage mistakes.
Access The Full Report Here:
What Are the Key Regional Markets in the Needle-Free Drug Delivery Devices Industry?
North America was the largest region in the needle-free drug delivery devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the needle-free drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15615
This Report Delivers Insight On:
1. How big is the needle-free drug delivery devices market, and how is it changing globally?
2. Who are the major companies in the needle-free drug delivery devices market, and how are they performing?
3. What are the key opportunities and risks in the needle-free drug delivery devices market right now?
4. Which products or customer segments are growing the most in the needle-free drug delivery devices market?
5. What factors are helping or slowing down the growth of the needle-free drug delivery devices market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
